The first six months of the year have painted a picture of extraordinary investor interest in digital health, but no quarter has made a stronger case than the past three months of record-breaking fundraising.
In Q3 2020, MobiHealthNews covered an unprecedented 109 investment deals and announcements that brought a total of more than $4.6 billion to digital health startups and health tech innovators.
This marks a substantial jump from Q1 2020's 82 deals for $2.9 billion and Q2 2020's 89 deals for $2.4 billion. Even more impressively, this quarter's total haul is roughly three times the amount MobiHealthNews reported during 2019's Q3, when investors' interest cooled to $1.55 billion across 66 deals. Notably, the sector has brought in nearly $10 billion in total investments in just nine months – handily outpacing MobiHealthNews' tallies for the entirety 2019 ($7.2 billion) and 2018 ($7.7 billion). With plenty more time left to go on the calendar, suffice it to say that 2020 is already well on track to become a banner year for the digital health industry.
Headliners for the quarter included nine-figure raises for insurtech and artificial intelligence-based drug-discovery startups, but a large volume of deals involved companies active in the telehealth and virtual care space – think Ro, Heal, Doctor On Demand, and MDLive on the upper end of the scale, and Eden Health, Nurx, Brightline and Medefer on the other. But this quarter's list also included a number of other major focus areas for the industry including remote monitoring, patient triage, prescription management, and data analysis.
Read on below to see the full list of fundings MobiHealthNews spotted in Q3, and click on the highlighted links to see their original coverage.
| Company | Round/Series | Amount (M) | Investors | What's it for | What they do |
| Bright Health | Series E | $500.00 | Tiger Global Management, T. Rowe Price Associates and Blackstone, NEA, Bessemer Venture Partners and Greenspring Associates. | These funds, in addition to existing capital, will be used to help the company expand into new geographies, Bright Health said. |
It operates in 43 markets across 13 states in the U.S. and currently offers individual, family and Medicare Advantage plans. Additionally, the tech-enabled company runs a consumer-minded platform consisting of web tools and a mobile app.
|
| XtalPi | Series C | $319.00 | SoftBank Vision Fund 2, PICC Capital, Morningside,Tencent, Sequoia China, China Life and SIG | XtalPi plans to use this funding to help make the pharmaceutical R&D process more efficient by expanding its ID4 platform. |
Its platform combines quantum physics, AI and cloud computing algorithms to assess how drugs react at a molecular level in order to help pharmaceuticals progress through clinical trials.
|
| Recursion Pharmaceuticals | Series D | $239.00 | Leaps by Bayer, Casdin Capital, Catalio Capital Management, Laurion Capital Management, Samsara BioCapital and others. | The funds will help Recursion fuel the clinical development of its therapeutic pipeline, and support continued investment into the development of its technology. |
Recursion is an artificial intelligence drug discovery company.
|
| Ro | Series C | $200.00 | General Catalyst, FirstMark Capital, Torch, SignalFire, TQ Ventures, Initialized Capital, 3L, BoxGroup and the Chernin Group | The company is adding remote patient monitoring, new diagnostic testing and urgent care to its offerings. |
Ro began as a men's sexual health and wellness platform, and now hosts several brands delivering direct-to-consumer health products.
|
| Grand Rounds | Unspecified | $175.00 | The round was led by the Carlyle Group. | According to the company, the new funds will go towards growing its “clinical navigation and virtual primary care.” |
The California-based company was founded in 2011 and started out as a second opinions site, but then pivoted to the health navigation space.
|
| Atomwise | Series B | $123.00 | B Capital Group, Sanabil Investments, DCVC, BV, Tencent, Y Combinator, Dolby Family Venture and AME Cloud Ventures. | The new funds are going to be put toward its internal drug development efforts and used to grow its partnership programs. |
The company uses artificial intelligence, specifically “convolution neural networks,” in order to assist with drug discovery efforts.
|
| Sema4 | Series C | $121.00 | BlackRock, Deerfield Management Company, Moore Strategic Ventures, Blackstone, Section 32, Oak HC/FT, Decheng and Connecticut Innovations | The funds will help Sema4 continue to grow and bring new "world-renowned partners" to its team. |
The spinout promotes data platforms focused on intelligent use of health research data, data-driven precision oncology, women's reproductive health and population health management.
|
| Tonal | Unspecified | $110.00 | L Catterton, Sapphire Sport, Shasta Ventures, Mayfield, Evolution Media and THVC, Delta-v Capital, the Amazon Alexa Fund, Mouse Partners, basketball players Stephen Curry and Paul George and professional golfer Michelle Wie. | With this raise, it aims to accelerate marketing initiatives while simultaneously ramping up its supply chain and logistics to meet demand. The company will also be targeting new software-based additions to its product, new fitness content and a research project with the Mayo Clinic. |
Tonal offers a special connected exercise machine with an AI-powered fitness software, all focused on the goal of strength training.
|
| Lyra Health | Series D | $110.00 | Addition, Adams Street Partners, Casdin Capital, Glynn Capital, Greylock, IVP, Meritech Capital Partners, Providence Ventures, Tenaya Capital and former Starbucks CEO Howard Schultz | The funds will help address new demand in the employee mental health market and expand Lyra Blended Health, its video teletherapy service. |
Lyra’s platform matches employees and their dependents to mental healthcare professionals and personalized, evidence-based treatments.
|
| Olive | Unspecified | $106.00 | General Catalyst and Drive Capital, Ascension Ventures, Oak HC/FT and SVB Capital. | The company did not specify how it would be deploying the new funds. |
Olive is a startup that develops artificial intelligence and automation software for providers.
|
| LinkDoc Technology | Series D+ | $102.00 | The company's support came from an undisclosed collection of prior backers, as well as newcomers such as CICC Capital, Youshan Capital and iFOF. | The company said it plans to continue fleshing out its big data platform and the tools within it. |
The company is a cloud-based platform offering a big data repository of medical data for clinical trial and clinical AI.
|
| Medly | Series B | $100.00 | Volition Capital, Greycroft, Horsley Bridge and Lerer Hippeau | The company plans to use the new funds to grow its platform and services. |
The tech-enabled pharmacy lets patients schedule same-day delivery over the phone, through text messages or an app.
|
| Heal | Series D | $100.00 | Humana | In addition to aligning the two companies' interests and delivering Heal's home care services to Humana members, the strategic investment will help Heal push into new regions including Chicago, Charlotte and Houston. |
Founded as a house call coordination app, Heal's service has expanded to support backend administrative work, telehealth follow-ups and telepsychology services.
|
| Biofourmis | Series C | $100.00 | SoftBank Vision Fund 2, Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. | As part of the shift, Biofourmis said that it would be using the new capital to develop, validate and commercialize digital therapeutics. |
Biofourmis is a Boston-based predictive-care startup that's leaning more and more into digital therapeutics.
|
| Doctor On Demand | Series D | $75.00 | General Atlantic and prior investors | The new money will fuel growth and expand access among U.S. patients. |
The San Francisco-based company provides virtual care services directly to consumers as well as through arrangements with health plans and employers.
|
| MDLive | crossover equity/debt financing | $75.00 | Sixth Street Growth and other unnamed investors. | The company said it would be prioritizing the expansion of its Virtual Primary Care platform with these funds, and will also be working to launch new supporting products and services for its members. |
MDLive provides a telehealth platform staffed by a network of certified clinicians capable of delivering virtual urgent care, dermatology, therapy and psychiatry services.
|
| Truepill | Series C | $75.00 | Oak HC/FT, Optum Ventures, TI Platform Management, Sound Ventures and YCombinator. | The company plans to use the funds to roll out a new at-home lab testing. The idea is that the company will combine testing, telehealth services and digital pharmacies. |
The company works with digital health brands, pharma manufacturers and health plans, to connect patients to telehealth and digital pharmacy services.
|
| Eargo | Series E | $71.00 | Gilde Healthcare, Longitude Capital, New Enterprise Associates, the Charles and Helen Schwab Foundation and Nan Fung Life Sciences. | The new funds will go towards expanding the commercialization of the product. |
The startup has developed app-connected, rechargeable hearing devices that can be purchased directly by the consumer.
|
| Sight Diagnostics | Series D | $71.00 | Koch Disruptive Technologies, Longliv Ventures and OurCrowd | The company said it plans to push into new regions and fuel R&D efforts so that its platform can be employed for additional diseases. |
Sight Diagnostics offers an FDA 510(k)-cleared complete blood count analyzer for use by frontline healthcare workers.
|
| Withings | Series B | $60.00 | Gilde Healthcare, Idinvest Partners, Pbifrance, BNP Paribas Development, ODDO BHF Private Equity and Adelie Capital | Withings aims to scale its B2B division globally, and accelerate development of new consumer devices. |
Best known as the maker of smart health devices for consumers, Withings has lately added a focus on B2B connected devices.
|
| Tempo | Series B | $60.00 | Northwest Venture Partners, General Catalyst, DCM, Bling Capital, SignalFire, Founder Fund and Y Combinator | This infusion of cash is slated to be used to increase manufacturing capacity, and open a second production studio. |
Tempo's in-home fitness system includes a screen and 3D-vision camera, which can scan the user’s movements 30 times per second, through which it delivers live workout classes.
|
| Nanox | Unspecified | $59.00 | Unnamed global investors | The funds intended to support worldwide rollouts of the Nanox.ARC. |
The Israeli company is developing a two-pronged offering comprising an in-hospital imaging device and a companion cloud software tool.
|
| Willow | Series C | $55.00 | NEA, Meritech Capital Partners and Lightstone Ventures and Perceptive Advisors. | With the new funding, Willow says it will continue developing its breast pump technology to come out with new versions of its product. |
To date, Willow has released three generations of its smart, in-bra breast pump. The latest iteration includes features that adjust the speed and rhythm of suction to match user preferences.
|
| Ready | Unspecified | $54.00 | GV, Deerfield Management Company, City Light Capital, Town Hall Ventures and Frist Cressey Ventures | The company said that it would be building out its operations and clinical programs with the new funds, and noted that its model will expand to include mental health, expanded point-of-care testing, vaccinations and more down the line. |
Ready's approach sends nurses, paramedics or EMT "Responders" to a patient's home, where they deliver acute or longitudinal care with the support of clinicians via telehealth.
|
| Cityblock | Series B+ | $53.50 | Kinnevik AB, AIMS Imprint of Goldman Sachs Asset Management, Alphabet and existing investors | The company plans to use the new funds to build out its services and technology for members. |
Cityblock uses tech to tackle health disparities, improving access to primary care, behavioral health and social services.
|
| Caption Health | Series B | $53.00 | DCVC, Atlantic Bridge, Edwards Lifesciences and Khosla Ventures | The company will be scaling its collaborations with research institutions, regional health systems and other providers. |
Caption's software includes an AI to guide professionals through cardiac imaging procedures, and automatic ejection fraction calculation.
|
| Ginger | Series D | $50.00 | Advance Venture Partners, Bessemer Venture Partners, Cigna Ventures, Kaiser Permanente Ventures and LinkedIn Executive Chairman Jeff Weiner | Ginger did not outline specific plans for the money. |
Founded a passive behavioral health monitoring platform, Ginger now delivers on-demand behavioral health services.
|
| PatientPop | Series C | $50.00 | HLM Venture Partners, Commonfund, Vivo Capital, Toba Capital, Transformation Capital and Silicon Valley Bank | PatientPop says it will use these funds to continue to provide practices with the tools they need to give patients the care they need both in-person and online. |
PatientPop's platform helps practices attract patients online through a customized website and search engine optimization.
|
| Thread | "Strategic commitments" | $50.00 | Water Street Healthcare Partners and JLL Partners | Thread will focus on expansion to more than 40 countries, development and implementation of COVID-19 clinical trial risk-mitigation tools, the introduction of new features for its platform, and the provision of worldwide and multilingual customer support. |
Thread specializes in decentralized clinical research technology.
|
| Thirty Madison | Series B | $47.00 | Polaris Partners, Johnson & Johnson, Maveron and Northzone | The company plans to use this money to make chronic condition management easier and more enjoyable for patients. |
Thirty Madison focuses on treating chronic health conditions through telemedicine. The company comprises three different brands, each targeting a different condition.
|
| Evidation Health | Series D | $45.00 | B Capital Group, McKesson Ventures, Section 32, Revelation Partners, Rethink Impact and SV Health Investors | The company will use its new funds to continue growing its study solutions business, as well as to kick off new programs for those participating in its app-based data collection efforts. |
The San Mateo company combines real-life patient data collected through more than 100 different sources in order to assess care or specific interventions for payer, pharma, systems and device-maker customers.
|
| Indigo Diabetes | Series B | $44.60 | Fund+, Ackermans&van Haaren, Capricorn Digital Growth Fund, imec.xpand and Titan Baratto | The new funds are expected to push forward the development of the product and the next research phase. |
The Gent-based startup is creating a continuous glucose monitoring sensor and corresponding app.
|
| Dialogue Technologies | Unspecified | $43.00 | Sun Life, Caisse de dépôt et placement du Québec, Portag3 Ventures, White Star Capital, HV Holtzbrinck Ventures, First Ascent Ventures and Walter Ventures | The company did not specify how the funds would be used. |
Dialogue is a telemedicine provider active within Canada.
|
| LifeSpeak | Unspecified | $42.00 | Round13 Growth Fund, Kensington Capital Partners and Roynat Capital. | The company said it would use the funds to expand access to LifeSpeak’s platform across health plans and employers. |
LifeSpeak is the maker of an employee mental-health-and-wellness digital platform.
|
| Exo | Series B+ | $40.00 | GlaxoSmithKline's Investor Action Potential Venture Capital fund | The company will be using the funds to wrap up product development for that device, and to bring its data and workflow apps to market. |
Exo is best known for its handheld ultrasound device.
|
| Science 37 | Unspecified | $40 | Lux Capital, Redmile Group, PPD, Inc., Novartis, Amgen, Sanofi Ventures, GV, Glynn Capital, LifeSci Ventures and Mubadala Ventures | The company said these new funds will help support growth of its platform and its international business. |
Science 37 enables decentralized clinical trials with digital recruitment tools and BYOD support.
|
| One Drop | Series C | $34.70 | Bayer | The company will be working to expand its platform beyond diabetes and into other chronic conditions. |
Oe Drop has developed a wireless blood glucose monitor system and self-management app.
|
| Hazel Health | Series C | $33.50 | Owl Ventures, Bain Capital Ventures, Uprising, Centene and UC San Francisco. | In the blog post announcement, the company said the funding would help Hazel "better serve our communities and provide preventative healthcare to more students," and highlighted insurance provider partnerships intended to increase access to the service. |
Through partnerships with school districts, Hazel Health operates virtual care clinics inside the school nurse's office.
|
| Lemonaid Health | Series B | $33.00 | Olive Tree Ventures, Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and other unnamed backers | Lemonaid will be using the new funds to increase the number of medical professionals under its roof, and to expand its offerings in asthma, hypertension, Type 2 diabetes and additional mental health care. |
The San Francisco-based telehealth platform and provider originally focused on D2C telehealth, but recently has increased its work with healthcare systems.
|
| NeuroPace | Equity raise | $33.00 | Accelmed Partners, Revelation Partners, Soleus Capital, KCK Group, OrbiMed Advisors and others. | Going forward, NeuroPace said that it would be accelerating the company's commercial growth and exploring broader indications for its neurostimulation system. |
NeuroPace's business is centered on its RNS System, an FDA-approved neurostimulator indicated for adults who experience frequent and disabling epileptic seizures from one or two sources within the brain, and who have tried two or more anti-seizure medications to no avail.
|
| Kindbody | Series B | $32.00 | Perceptive Advisors, RRE, GV, Freemark Capital, Rock Springs Capital, Goodgrower, Claritas Capital and NFP | The startup will be using its new funding to expand its owned physical locations and network of partner clinics, both in the U.S. and internationally. |
Kindbody is a women's health startup combining virtual care with face-to-face visits.
|
| Lumeon | Series D | $30.00 | Optum Ventures, Endeavor Vision, LSP, MTIP, IPF Partners, Glide and Amadeus Capital Partners | Lumeon is looking to expand the reach of its platform with these funds. |
Lumeon's primary offering is an EHR-integrated tool incorporating clinical and administrative data streams to guide and automate patient care.
|
| Reify Health | Series B | $30.00 | Battery Ventures, Sierra Ventures and Asset Management Ventures | The company will continue to expand its platform. |
The startup's StudyTeam platform looks to speed up clinical trial enrollment and reduce workload burdens by handling redundant processes and highlighting data-driven insights.
|
| Medigate | Series B | $30.00 | Partech, Maor Investments, YL Ventures, U.S. Venture Partners and Blumberg Capital. | Medigate kept its plans for the new funds vague, saying only that the money will help "expand Medigate's leadership and availability to healthcare organizations needing advanced protection, visibility and cost control." |
Medigate's platform secures networked medical devices or Internet of things products that are connected to EHRs, device servers and other enterprise systems. It automatically identifies devices located in the network, classifies them by type and then analyzes their specialized protocols, communications and behaviors.
|
| Bridge Connector | Series B | $25.50 | Axioma Ventures and all other prior backers | The startup said that it would be using the funds to support its increasing market share and its new Destinations "integration-platform-as-a-service." |
Bridge Connector is a vendor-agnostic healthcare interoperability startup.
|
| Truepill | Series B | $25.00 | TI Platform Fund, Optum Ventures, Initialized Capital, Sound Ventures and other unnamed backers | The company said that it will be working to expand its product offerings; improve its integrated, direct-to-patient products; and meet increasing demand. |
Truepill is a digital pharmacy that focuses on APIs, telehealth practitioners and pharmacy fulfillment services.
|
| Freeletics | Series B | $25.00 | The round was led by JAZZ Venture Partners and Causeway Media Partners, with contributions from KKCG. | With this financial support, Freeletics plans to develop new technologies, expand into new markets – especially in the U.S. – and create new business verticals. |
Founded in 2013, Freeletics uses AI technology to coach users through digital workouts and meal plans.
|
| RapidAI | Series B | $25.00 | The round was headed by Lennertz & Co. | The company said the raise would help advance its platform. |
The company's platform uses AI to build high-quality CTs and MRIs, with the end goal of helping clinicians make faster and more accurate treatment decisions for patients with strokes or aneurysms.
|
| Eden Health | Series B | $25.00 | Flare Capital Partners, Stone Point Capital, Greycroft, PJC, Max Ventures and Aspect Ventures | Eden did not specify its plans for the money. |
Eden Health is a direct-to-employer healthcare provider that specializes in virtual primary care, insurance navigation and workplace pop-up clinics.
|
| PicnicHealth | Series B | $25.00 | The round was led by Felicis Ventures. | The company said that the new funds will be put towards new medical research that is based on real-world data that it captures from its users. |
PicnicHealth is a startup that helps patients access and share their medical records.
|
| AristaMD | Series B | $24.00 | Ascension Ventures and .406 Ventures | These investments will be used by AristaMD to grow its platform into new health systems across the U.S. |
AristaMD developed AristaMD is an e-consult platform where PCPs can virtually connect with either specialists within their health system or those provided by the company’s panel of board-certified specialists.
|
| Joint Academy | Series B | $23.00 | Kinnevik, Karl-Johan Persson (H&M chairman) and Alfvén & Didrikso. | The Series B round will help the company accelerate in the US and expand its offering throughout Europe. |
Joint Academy is a clinical evidence-based digital treatment for chronic joint pain, which connects patients with licensed physical therapists.
|
| Nurx | Series C (closed in May) | $22.50 | Trustbridge, Comcast Ventures, Wittington Ventures, Union Square Ventures and Kleiner Perkins Digital Growth Fund | Nurx said that the funds would help address growing demand for its offerings, and would support the introduction of new services for headaches and migraines. |
Nurx made its name through telehealth prescription and delivery of birth control pills, but recently expanded its offerings to include other areas of reproductive health.
|
| Paige | Series B | $20.00 | Goldman Sachs Merchant Banking Division and Healthcare Venture Partners | The new funds will be used to continue the growth of Paige's platform by working with biopharma companies to create diagnostic and clinical improvements to patient care. |
Paige develops artificial intelligence tools to help oncologists and pathologists make faster decisions about caring for cancer patients.
|
| NowRx | Series B | $20.00 | Crowdfunding | The company will be establishing more of its "micro-fulfilment centers" to extend its areas of operation, as well as to accelerate the technology of its software platform. |
NowRx combines proprietary pharmacy management software with last-mile logistics to provide a consumer app that simplifies orders and ensures prompt deliveries.
|
| Sidecar Health | Unspecified | $20.00 | Cathay Innovation, Comcast Ventures, Kauffman Fellows, GreatPoint Ventures, Morpheus Ventures and Anne Wojcicki | Sidecar Health will use these funds to push into new markets and expand its team. |
Sidecar's app allows users to customize their annual coverage amount and options, and includes a price comparison tool for viewing different services from local providers.
|
| Brightline | Series A | $20.00 | Oak HC/FT, Blue Shield of California, Blue Cross Blue Shield of Massachusetts, Boston Children’s Hospital, SemperVirens VC, Rock Health and City Light Capital | Brightline is looking to improve its technology platform, and to build out its telehealth capabilities and the number of treatment programs. It will also be making new hires. |
The startup formerly known as Emilio offers a virtual platform that connects children with behavioral health needs to live clinicians and clinical social workers.
|
| Aetion | Series B | $19.00 | Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates | Aetion said that it would be working to expand the capabilities of its Aetion Evidence Platform and to further the company's push for worldwide standards in RWE. |
Founded in 2013, the company's platform provides insights from RWE to decision-makers across life sciences, health insurance and provider organizations.
|
| Papa | Series B | $18.00 | Comcast Ventures, Canaan, Initialized Capital, Sound Ventures, Pivotal Ventures with Magnify Ventures, Operator Partners and others. | Papa said in its funding announcement that the money would go toward growing its staff and supporting the aforementioned regional expansion. The company also plans to further build out its tech platform. |
Papa's platform connects college and nursing students with seniors who might need help with tasks like transportation, grocery shopping, prescription pickups and technology comprehension – or those who are just in need of virtual or in-person companionship.
|
| mPulse Mobile | Series C | $16.00 | Optum Ventures, HLM Venture Partners, OCA Ventures, SJF Ventures, Echo Health Ventures and Rincon Ventures | The company will be expanding its conversational AI capabilities, enhancing its client engagement analytics platform and expanding its engagement tools. |
The company uses AI to automate conversations between consumers and healthcare organizations.
|
| optimize.health | Series A | $15.60 | U.S. Venture Partners led the round, which also saw support from Foundry Group, Daher Capital, Openview Venture Partners, Bonfire Ventures and SOSV. | With the funds, optimize.health said it will be expanding its product and engineering teams, expands its sales and marketing operations, and tack new features and user experience improvements onto its platform. |
The company launched with a focus on smart pill bottle caps, but recently pivoted to sell a remote patient-monitoring software platform that includes analysis tools for providers and engagement hooks for patients.
|
| Meditopia | Series A | $15.00 | Creandum and Highland Europe | The funds will be used to further its expansion and services. |
Meditopia provides resources specifically designed to address cultural differences in the way topics such as sexuality are perceived around the world
|
| Activ Surgical | Unspecified | $15.00 | ARTIS Ventures, LRVHealth, DNS Capital, GreatPoint Ventures, Tao Capital Partners and Rising Tide VC | Activ Surgical plans to expand its ActivEdge platform in Europe and accelerate its commercialization in the U.S. |
The company develops hardware-agnostic technology that uses computer vision and robotics to drive autonomous and collaborative surgical procedures.
|
| Klara | Unspecified | $15 | Google's Gradient Ventures, First Cressey Ventures, FirstMark Capital, Lerer Hippeau, Project A and Stage 2 Capital | These funds will be used for new hires and improvements to its offerings, including greater AI-based automation for patient intake and payments |
Klara has built a digital patient messaging and engagement platform.
|
| Genome Medical | Series B extension | $14.00 | Samsung Catalyst Fund, Genome's founders, existing investors and others | The raise will help the startup accelerate development of the platform, first by expanding the patient-engagement and care-navigation platform for cancer, reproductive health and pharmacogenomics use cases. |
Genome Medical offers patient-facing virtual visits and provider-facing consultations with genetic experts through its "telegenomics" platform.
|
| Osso VR | Series A | $14.00 | Kaiser Permanente Venture, SignalFire, GSR, Scrum Ventures, Leslie Ventures and OCA Ventures. | The company did not specify how it would be deploying the new funds. |
Osso VR is a virtual reality platform for surgery training.
|
| GYANT | Series A | $13.60 | Wing Venture Capital, Intermountain Ventures, Grazia Equity, Alpana Ventures, Techstars Ventures and Plug and Play Ventures | GYANT said that the new funds will help further its tech platform and support greater interoperability for its customers. |
GYANT's care-navigation business looks to serve as the "digital front door" for healthcare-provider organizations. The AI tool engages patients via chat to uncover their needs and direct them toward the services or tools they may need.
|
| Cecelia Health | Series B | $13.00 | Rittenhouse Ventures, Endo Investors, Boston Millennia Partners, SustainVC, G100 Capital and others | Cecelia will be using the funds to scale and accelerate market adoption of its virtual coaching and telemedicine services. |
The company was initially founded as Fit4D, where it provided access to certified diabetes educators (CDE) for scalable one-on-one coaching. Its rebranding is focused on expanding into other chronic conditions.
|
| Medefer | Unspecified | $12.80 | The round was led by Nickleby Capital. | The funds are primarily for growing the company. The startup plans to do this by investing in staff and tech services, as well as product development and contracts. |
Medefer is split into three services: a healthcare provider, virtual outpatient pathway and a tech platform for doctors to conduct virtual visits. Currently the platform can deliver healthcare within the UK's NHS system.
|
| Noyo | Series A | $12.50 | Costanoa Ventures and Spark Capital led the round with participation from Homebrew, Fika Ventures, Precursor Ventures, Core Innovation Capital, Garuda Ventures and Webb Investment Network. | The startup plans to use the funds in order to hire new staff members and expand its product line. It will also put the infusion of cash towards expanding partnerships with new insurers and benefits platforms, the company said. |
The company is developing carrier-agnostic APIs that can communicate between different insurance and health organizations.
|
| Castor | Series A | $12.00 | Two Sigma Ventures, Hambrecht Ducera Growth Ventures and INKEF Capital | The funding will be used to make clinical research more patient-centric, create more meaningful data and address underserved communities. |
Castor aims to simplify the research process through a platform that captures and integrates data from any source into one system.
|
| Oncomfort | Series A | $11.80 | Debiopharm, Crédit Mutuel Innovation, Belgium's Walloon Region Regional Investment Company and others | The company will be looking to continue development of the platform, make new hires and accelerate its push into new European and American markets. |
Oncomfort was founded in 2017, and launched its SedaKit for Digital Sedation product as an alternative to medications in June of last year.
|
| Bodyport | Series A | $11.20 | Beehringer Ingelheim Venture Fund, Playground Global, Initialized Capital and other unnamed backers | Bodyport said that the raise will be used to "deepen key health partnerships," as well as to kick off a remote monitoring-based "virtual cardiac clinic." |
Bodyport makes a connected bathroom scale for monitoring cardiac biomarkers.
|
| Siilo | Series A | $11.10 | VC Heal Capital, Philips Health Technology Venture Fund and EQT Ventures | Siilo says it will continue to expand its product offering, increase network growth and make new hires. |
Siilo provides a free messenger app for individuals and teams to coordinate patient care, expand their professional network, and reduce time making decisions by exchanging best practices.
|
| Qualio | Series A | $11.00 | Storm Ventures, Sorensen Ventures, MHS Capital, Frontline Ventures and the founders of Flatiron Health and Plaid | The startup did not outline how the funds would be deployed. |
Qualio's cloud-based platform looks to replace paper process-based quality management software with an easy-to-implement, easy-to-scale alternative.
|
| Infermedica | Series A | $10.25 | European Bank for Reconstruction and Development, Heal Capital, Karma Ventures, Inovo Venture Partners and Dreamit Ventures. | This infusion of cash will support its R&D efforts, bolster its current features and support expansion to Germany and the U.S. |
Infermedica's B2B-focused AI triage system includes a symptom checker, a call center triage feature and an API.
|
| Movano | Bridge funding | $10.00 | Tri-Valley Ventures | Movano said in its announcement that its newest funds will help finalize production silicon and kick-start preparations for initial user trials. |
Movano is developing a connected CGM wearable that doesn't require the user to break the skin with a needle or prick.
|
| Sprout | Seed funding | $10.00 | General Catalyst, Bling Capital and Felicis Ventures | Sprout did not outline specific plans for its seed funding in the announcement. |
Sprout is an autism care and treatment program combining in-home assessments with a tech platform.
|
| Cohere Health | Series A | $10.00 | Flare Capital Partners, Define Ventures and an unnamed "leading national strategic partner." | The company did not outline specific plans in its announcement |
Cohere Health's system places a focus on transparent care over siloed processes, and value-based agreements over fee-for-service.
|
| Voiceitt | Series A (closed June 30) | $10.00 | Viking Maccabee Ventures, Microsoft's M12, AMIT Technion, Cahn Capital Corp, Connecticut Innovations, AARP, Quake Capital, SLJ Family Office, Dreamit Ventures and The Disability Opportunity Fund | The company did not outline its plans for the money. |
Voiceitt’s application enables people with severe speech impairments to communicate by voice and translates unintelligible and atypical speech in real time.
|
| Siren | Series B | $9.00 | Manta Ray, Mighty Capital, David Helgason, Anathem Ventures, Khosla Ventures, DCM and Founders Fund | The company said that it has been, and continues to, grow its team to meet the higher demand for its product. |
Taking the form of smart socks, the garments connect to a broader software application that allows a podiatrist to look out for inflammation or other risks that presage diabetic foot ulcers.
|
| StuffThatWorks | Seed funding | $9.00 | Bessemer Venture Partners, 83North and Ofek Ventures | The company did not disclose its plans for the funds. |
StuffThatWorks is a community platform that uses AI to encourage patients to share their treatment experiences.
|
| NovaSight | Series A | $8.00 | Rimonci Capital and other strategic investors | The funds will support a pivotal study and assist with future development. |
NovaSight's lead product is a device treatment for myopia, or lazy eye.
|
| Podimetrics | Series B-2 | $8.00 | Polaris Partners, Rock Health, Norwich Ventures and Scientific Health Development | The company's new funds will support Podimetrics' growth while accelerating its work with the VA and other nationwide commercial payers. |
Podimetrics makes a connected platform for diabetic foot-ulcer detection, consisting of a cellular-connected SmartMat for use in the home and a corresponding clinician-facing dashboard.
|
| K4Connect | Series B extension | $7.70 | Forte Ventures | The company said that its new funds will speed up the development and deployment of new connected technologies for older adults. |
K4Connect offers senior and disability technology to continuing care, independent living and assisted living communities.
|
| FraudScope | Series A | $7.00 | QED Investors, Brewer Lane Ventures, the GRA Venture Fund, Spider Capital, Mosley Ventures and TechSquare Labs | FraudScope plans to use the capital to scale its team and expand product offerings. |
FraudScope provides health systems a workflow tool that can detect and investigate fraud, waste and abuse schemes using AI technology.
|
| Neurovalens | Unspecified | $6.56 | IQ Capital, Wharton Asset Management Company, The Angel CoFund (ACF), Techstart Ventures, Clarendon Fund Managers and the Government’s Future Fund | The funding will be used for clinical trial research and development in the UK and abroad, as well as hiring additional staff. |
Neurovalens’ technology aims to influence the brainstem and hypothalamus in a non-invasive way to cure or treat neurological diseases, without the need for implanted electrodes.
|
| Nucleai | Series A | $6.50 | Debiopharm | The Israeli startup plans to continue development on its platform and expand commercial reach to potential pharma and biotech business partners. |
Nucleai develops an AI platform for precision oncology research and treatment decision-making.
|
| Immertec | Series A extension | $6.00 | Revolution's Rise of the Rest Seed Fund, Benvolio Group and PAR | These new funds will help expand into new areas and hire new staff, among which would be a COO. |
Immertec offers virtual reality surgical training technology.
|
| uMotif | Series A | $5.86 | The round was led by existing investor AlbionVC. | The funding will accelerate uMotif’s growth and enable further development of its patient-centric and decentralized approach to clinical studies and enable expansion into new study types and more high-demand territories. |
uMotif is a UK-based data capture software company.
|
| Retina-AI Health | Series A | $5.20 | Bill Smith | The company is pushing its product through FDA regulatory approval. |
The company is developing screening software for diabetic retinopathy detection.
|
| Skin Analytics | Series A | $5.20 | Hoxton Ventures led the raise, which also saw participation from Nesta and Mustard Seed Ventures. | With the money in hand, the company said it's looking to strike new deals with the U.K.'s NHS. Following up on a Breakthrough Device Designation from the FDA, it also is looking to expand its business into the U.S. |
Skin Analytics is a U.K. startup building an AI-based early detection tool for skin cancer.
|
| Noteworth | Seed funding | $5.00 | Laconia Capital Group, Draper Associates, Frontier Ventures, Techstars Ventures, Wavemaker360 and Springtide Capital. | The startup said that it will be using its new funds to build out its operations, make new strategic hires and further support the Noteworth platform. | The company's software supports care through data collection and management, patient engagement and remote patient-monitoring. |
| Trellus Health | Seed funding | $5 | Mount Sinai Health System and EKF Diagnostics | The company did not specify an immediate goal for its new funds. |
Trellus offers a connected care platform for treatment of chronic diseases such as inflammatory bowel disease.
|
| BestDoctor | Unspecified | $4.50 | AddVenture, Target Global, LVL1 fund | The company did not specify how the funds would be used. |
The company offers virtual health consultations and access to mental health therapists 24/7 for employer customers.
|
| Roundtrip | Unspecified | $4.00 | Motley Fool Ventures, Zoll Medical Corporation, UH Ventures and Gray Ferry Capital | The new funds will be put towards growing its geographical footprint and its sales force. It also plans to build up its portfolio of health plans and technology integrations. |
The company offers a platform that coordinates patients' non-emergency medical transportation.
|
| SeamlessMD | Series A | $4.00 | MEDTEQ+, Hikma Ventures, Anges Québec, AIoT Health and health IT entrepreneur Sanjay Malaviya. | SeamlessMD plans to deepen its library of digital care plans and improve the machine learning algorithm it employs to predict risk. |
The SeamlessMD platform is used by health systems to monitor and stay connected with patients throughout a variety of different healthcare journeys, including surgery, oncology and chronic condition care.
|
| DrDoctor | Series A | $3.80 | Ananda Impact Ventures and 24Haymarket. | The funding will be used to expand its digital services platform and increase its reach across the U.K. Specifically, it will allow DrDoctor to expand its remote-patient-management and data solutions, reducing face-to-face appointments and helping improve clinical risk stratification. |
DrDoctor offers a digital platform for patient communications and other hospital tasks.
|
| Sift Healthcare | Unspecified | $2.80 | Rock River Capital Partners, Winnebago Seed Fund and others. | These funds will help build out its data science and data engineering teams as it looks to meet new demands for its AI tools. |
Sift is a healthcare payments and revenue cycle management startup.
|
| iWEECARE | pre-Series A | $2.40 | TransLink Capital, Taiwan’s National Development Fund, BE Capital, Taiwan Surface Mounting Technology Corp (TSMT), NCTU Angel Club, Might Electronic, Verge HealthTech Fund and Darwin Venture. | The funds will be used to accelerate marketing activities to address the demand for remote patient monitoring technologies in the United States and China. |
The company is the developer of the world’s smallest continuous temperature monitoring product, Temp Pal.
|
| LuminDx | Seed funding | $2.00 | Argon VC, Flare Capital, Good Growth Capital, Techstars, TBD Angels, Andy Palmer, Bob Davoli, Esther Dyson and William Crawford | The company will now be able to access large image collections of skin conditions, improve its platform's accuracy and expand its team. |
The company developed a smartphone app to help frontline providers identify likely skin conditions using machine learning and computer vision.
|
| Mobio Interactive | seed funding | $1.80 | Verge HealthTech Fund, Atlas Asset Management, Creative Ventures and SOSV. | The funds will be used to advance the deep tech and clinical validation of Am Mindfulness (Am), which was the first and currently only meditation app which the company claims to outperform placebo in randomized controlled trials. |
Mobio Interactive develops and commercializes clinically validated and objectively quantified software to prevent, measure and treat mental illness.
|
| Dozee | Unspecified | $1.70 | Prime Venture Partners, YourNest Venture Capital and 3One4 Capital. | With this, company hopes to expand its market outreach and enhance the capabilities of its technology. Of note, it also is looking to global regulatory certifications such as FDA clearance. |
Dozee is an Indian contactless remote-monitoring startup.
|
| Transformative | Seed funding | $1.70 | Tera Ventures, Wellcome Trust and InHealth Ventures. | The startup will use its seed funding to obtain FDA clearance for its first product and to begin developing technologies that predict other life-threatening conditions. |
Transformative’s software predicts sudden cardiac arrest by analyzing data from patient monitoring devices.
|
| Clearstep Health | pre-Seed funding | $1.30 | RRE Ventures, Newark Venture Partners and OCA Ventures | The company will be making new hires to support product development and business development. |
Clearstep makes an AI care navigation tool for in-person or virtual care.
|
| Raccoon.World | Seed funding | $1.05 | Quarter Partners and others | The funding will be used on the development of this new product functionality, as well as conducting additional clinical trials for it. |
The startup will use the funding to enhance its Raccoon.Recovery rehabilitation platform in helping people recover after injuries and neurological diseases and aims to expand its existing markets in Germany and Poland.
|
| HealtheMed | Seed funding | unspecified | The round was funded by angel investors. | The company said that its seed funding would help launch this service, and expanded into additional U.S. markets. |
HealtheMed's approach relies on a two-way synchronous communication system consisting of a large TV, attached cameras and a microphone. This system is installed in Minnesota Medicaid members' homes through a partnership with Best Buy's Geek Squad.
|
| Neuronostics | Unspecified | unspecified | unspecified | The company received funds to develop an AI-based system for more accurate diagnosis of epilepsy and to monitor response to treatment of anti-epileptic drugs (AEDs). |
The platform is called BioEp and works by creating mathematical models of the brain using segments of electroencephalogram (EEG) recordings.
|
| Celsium | Unspecified | Undisclosed | Growthdeck | The funds will support Celsium's expansion. |
Celsium’s device is an armpit-mounted temperature sensor, which connects via Bluetooth to a smart monitoring platform.
|
